Osteoporosis Treatments Compared to Assess Effects on Bone Mineral Density
The network meta-analysis compared the effects of 9 osteoporosis drugs on BMD.
All articles by Cassandra Pardini, PharmD
Hypoglycemia Risk With Concomitant ACEI, Insulin Secretagogue Use Examined
The main outcome of the study was hospital presentation due to serious hypoglycemia.
ACE Inhibitors vs ARBs for First-Line Hypertension Treatment
Currently, ACE inhibitors and ARBs are both recommended as first-line therapies for the treatment of hypertension according to US and European guidelines.
Heart Failure With Mildly Reduced Ejection Fraction: Treatment Options Explored
Despite an increasing emphasis on HFmrEF over the past several years, there is a lack of authoritative guidance surrounding therapeutic approaches for these patients.
Medication Organizers Often Contain “One Pill Can Kill” Meds
While known to increase patient compliance, medication organizers, such as blister packs and pill boxes, have also been associated with unintentional pediatric medication exposures.
Fish Oil Products: Do The Serving Sizes Add Up to Cholesterol Benefits?
Omega-3 fatty acids, including eicosapentaenoic acid (EPA) and docosehexaenoic acid (DHA), have been found to be associated with cardiovascular health benefits.
Black Cohosh Appears Safe, but May Not Benefit Women With PCOS-Related Infertility
Black cohosh is a natural phytoestrogen product occasionally used in the management of PCOS-related infertility.
Graded Administration of Second COVID-19 Vaccine Dose After Hypersensitivity
Current recommendations surrounding the administration of the second COVID-19 vaccine dose to patients who experience an immediate hypersensitivity reaction to the first dose are conflicting.
Medicare Claims Database Useful for Detecting Arrhythmogenic Risk of QT-Prolonging Drugs
Study authors evaluated whether using an observational study that includes Medicare claims data could detect the proarrhythmic risk of medications known to prolong the QT interval.
Higher Levothyroxine Doses Linked to Increased AF Risk in Older Patients
To evaluate the association, the study authors utilized healthcare databases from Ontario, Canada to identify adults 66 years of age and older with no history of AF who filled at least 1 prescription for levothyroxine.
- Loading...
Loading...
Next post in Thyroid
Loading... 
Loading...